Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VALNEVA-54466/news/Valneva-Announces-Positive-Initial-Results-for-Second-Phase-2-Study-of-Lyme-Disease-Vaccine-Candidat-31576145/?utm_source=whatsapp&utm_medium=social&utm_campaign=share